Researchers evaluated the incidence and risk factors for ketoacidosis among adults with type 2 diabetes receiving treatment with SGLT2 inhibitors.

Prolonged sleep habits are associated with a higher risk for incident or worsening diabetic nephropathy among patients with type 2 diabetes.

While lower-frequency IET may be sufficient to maintain BP reductions over the short term, higher frequencies are required to preserve the full CV benefits.

New York Gov. Kathy Hochul has declared a statewide emergency as measles spreads through rural parts of the state.

The prevalence of neurodiversity is increased among individuals diagnosed with type 2 diabetes (T2D) early in life.

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.

Compared with standard care alone, a hybrid lifestyle intervention did not significantly improve weight loss in adults with obesity.

For adults aged 60 to 69 years, lower cognitive functioning in global cognition and perceptual speed is associated with increased stroke risk.

Continuous glucose monitoring threshold alerts improve time in range and reduce time above range for hospitalized adults with diabetes.

The FDA granted Priority Review to the NDA for infigratinib, an oral FGFR3 inhibitor for pediatric achondroplasia, with a PDUFA action date of February 4, 2027.

Eliminating television commercials for unhealthy foods and beverages is projected to decrease obesity rates among children and adolescents.

For postmenopausal women with early-stage HR+ breast cancer, long-term adherence to AIs is linked to greater cardiometabolic risks than tamoxifen.